Patent 11974934 was granted and assigned to ReShape Lifesciences on May, 2024 by the United States Patent and Trademark Office.
Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.